DK356075A - Fremgangsmade til fremstilling af 1-oxacephemer samt mellemprodukter dertil - Google Patents

Fremgangsmade til fremstilling af 1-oxacephemer samt mellemprodukter dertil

Info

Publication number
DK356075A
DK356075A DK356075A DK356075A DK356075A DK 356075 A DK356075 A DK 356075A DK 356075 A DK356075 A DK 356075A DK 356075 A DK356075 A DK 356075A DK 356075 A DK356075 A DK 356075A
Authority
DK
Denmark
Prior art keywords
oxacephemes
procedure
preparation
intermediate products
products
Prior art date
Application number
DK356075A
Other languages
Danish (da)
English (en)
Inventor
S Wolfe
Original Assignee
Univ Kingston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kingston filed Critical Univ Kingston
Publication of DK356075A publication Critical patent/DK356075A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK356075A 1974-08-06 1975-08-05 Fremgangsmade til fremstilling af 1-oxacephemer samt mellemprodukter dertil DK356075A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB34614/74A GB1510794A (en) 1974-08-06 1974-08-06 1-oxacephems and intermediates therefor

Publications (1)

Publication Number Publication Date
DK356075A true DK356075A (da) 1976-02-07

Family

ID=10367850

Family Applications (1)

Application Number Title Priority Date Filing Date
DK356075A DK356075A (da) 1974-08-06 1975-08-05 Fremgangsmade til fremstilling af 1-oxacephemer samt mellemprodukter dertil

Country Status (12)

Country Link
US (1) US4013653A (fi)
JP (1) JPS5141385A (fi)
AT (1) AT342769B (fi)
BE (1) BE832174A (fi)
CA (1) CA1052787A (fi)
CH (1) CH616681A5 (fi)
DE (1) DE2531843A1 (fi)
DK (1) DK356075A (fi)
FI (1) FI63237C (fi)
FR (3) FR2281119A1 (fi)
GB (1) GB1510794A (fi)
NL (1) NL7509353A (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226866A (en) * 1972-11-06 1980-10-07 Merck & Co., Inc. Novel antibiotic analogues of cephalosporins
US4108992A (en) * 1975-05-10 1978-08-22 Beecham Group Limited Cephalosporin analogues and compositions
US4143038A (en) * 1975-11-12 1979-03-06 Shionogi & Co., Ltd. Cephalosporin analogues
CA1085392A (en) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporins
JPS607635B2 (ja) * 1976-04-27 1985-02-26 塩野義製薬株式会社 オキサゾリジン化合物
JPS609515B2 (ja) * 1976-08-09 1985-03-11 塩野義製薬株式会社 3′−ノルオキサセファロスポリン類
US4197402A (en) * 1976-08-09 1980-04-08 Shionogi & Co., Ltd. Cephalosporin analogues
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
US4187375A (en) * 1976-09-08 1980-02-05 Smithkline Corporation Process for preparing oxazine ring compounds
US4089956A (en) * 1976-09-08 1978-05-16 Smithkline Corporation 7-Acylamino-8-oxo-3-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid derivatives and bactericidal compositions and use thereof
US4443598A (en) * 1977-02-15 1984-04-17 Shionogi & Co., Ltd. 1-Oxadethiacepham compounds
GB1557552A (en) * 1977-02-15 1979-12-12 Shionogi & Co 1 oxadethiacepham compounds
US4478997A (en) * 1977-02-15 1984-10-23 Shionogi & Co., Ltd. 1-Oxadethiacepham compounds
JPS53105491A (en) 1977-02-25 1978-09-13 Shionogi & Co Ltd Oxazolinoazethidinylbutyrylic acid derivatives
CA1100962A (en) * 1977-04-28 1981-05-12 Yoshio Hamashima Haloarylmalonamidooxacephalosporins
IT1102408B (it) * 1977-12-23 1985-10-07 Fujisawa Pharmaceutical Co Composti analoghi della cefalosforina e procedimenti per la loro preparazione
US4243588A (en) * 1979-06-19 1981-01-06 Eli Lilly And Company Process for novel oxazolinoazetidinones
JPS5690088A (en) * 1979-11-02 1981-07-21 Meiji Seika Kaisha Ltd Novel cephalosporin analog compound
US4301282A (en) * 1980-09-17 1981-11-17 Eli Lilly And Company 1-Oxa-β-lactam antibiotics
US4500456A (en) * 1981-03-09 1985-02-19 Eli Lilly And Company Preparation of 4-fluoroazetidinones using FClO3
US4368156A (en) * 1981-03-09 1983-01-11 Eli Lilly And Company Preparation of 4-haloazetidin-2-ones from 4-sulfinoazetidin-2-ones
US4391975A (en) * 1981-12-15 1983-07-05 Queen's University At Kingston Process for 1-oxacephem derivatives
DE3225269A1 (de) * 1982-07-06 1984-01-12 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 7-amino-1-dethia-1-oxa-3-hydroxymethyl-cephem-4-carbonsaeuren
JPS59104389A (ja) * 1982-12-06 1984-06-16 Shionogi & Co Ltd オキサセファム誘導体
US4558123A (en) * 1983-07-22 1985-12-10 Eli Lilly And Company 3-Exomethylene cephalosporins
JP2525170B2 (ja) * 1987-03-09 1996-08-14 大塚製薬株式会社 2―オキサイソセフェム誘導体の製造方法
US5412094A (en) * 1993-06-28 1995-05-02 Eli Lilly And Company Bicyclic beta-lactam/paraben complexes
SK13897A3 (en) 1996-02-06 1998-05-06 Pliva Pharm & Chem Works 3-bromo- and 3,3-dibromo-4-oxo-1-azetidines, method for preparation thereof and their use
HRP970146A2 (en) * 1997-03-13 1998-10-31 Mice Kovacevic Epoxi-azetidines, preparation and use
WO2003011298A1 (en) * 2001-08-03 2003-02-13 Chirologix Pharmaceuticals Inc. Antibacterial oxazinones and methods for their use and synthesis
US20030232820A1 (en) * 2001-08-29 2003-12-18 Saul Wolfe Method for synthesizing oxazinones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1914366A1 (de) * 1969-03-21 1970-10-01 Bayer Ag Arzneimittel auf Basis neuer,heterocyclischer Verbindungen
CH581140A5 (fi) * 1971-05-28 1976-10-29 Lilly Co Eli

Also Published As

Publication number Publication date
FR2318157B1 (fi) 1979-03-09
GB1510794A (en) 1978-05-17
FI752225A (fi) 1976-02-07
US4013653A (en) 1977-03-22
CA1052787A (en) 1979-04-17
FI63237B (fi) 1983-01-31
CH616681A5 (fi) 1980-04-15
BE832174A (fr) 1975-12-01
FR2281119A1 (fr) 1976-03-05
AT342769B (de) 1978-04-25
FI63237C (fi) 1983-05-10
FR2318158A1 (fr) 1977-02-11
JPS5141385A (en) 1976-04-07
FR2318157A1 (fr) 1977-02-11
FR2318158B1 (fi) 1979-03-23
DE2531843A1 (de) 1976-02-19
ATA599175A (de) 1977-08-15
FR2281119B1 (fi) 1982-04-23
NL7509353A (nl) 1976-02-10

Similar Documents

Publication Publication Date Title
DK356075A (da) Fremgangsmade til fremstilling af 1-oxacephemer samt mellemprodukter dertil
NO145075C (no) Kontinuerlig fremgangsmaate til fremstilling av alkoksysilaner
DK144298C (da) Fremgangsmaade til fremstilling af alkyl-tert-butylethere
DK363275A (da) Detergent samt fremgangsmade til fremstilling heraf
SE7513085L (sv) Forfarande for framstellning av etrar
DK269175A (da) Fremgangsmade til fremstilling af d-phenylglycinamid og l-phenylglycin
DK136398C (da) Fremgangsmaade til fremstilling af et analgetisk-antipyretisk praeparat
DK385475A (da) Fremgangsmade til fremstilling af secoprostaglandiner
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
DK222975A (da) Fremgangsmade til fremstilling af polysocyanater og disses anvendelse
DK310675A (da) Diphenylethere samt fremgangsmade til fremstilling deraf
DK141849C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK574075A (da) Fremgangsmade til fremstilling af 2-methoxybenzamider
DK206375A (da) Fremgangsmade til fremstilling af thiaprostaglandiner
SE432936B (sv) Oligomera n-alkyliminoalaner samt forfarande for framstellning av desamma
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
DK583775A (da) Fremgangsmade til fremstilling af 3-fluorbenzodiazepiner
DK528475A (da) Fremgangsmade til fremstilling af tetramethylethylendiamin
DK543875A (da) Fremgangsmade til fremstilling af hydroxyphenylacetonitriler
SE7510082L (sv) Polypeptid samt forfarande for framstellning av densamma
DK273875A (da) Sprojte samt fremgangsmade til fremstilling af samme
DK143332C (da) Fremgangsmaade til fremstilling af ortho-hydroxyalkylerede phenoler
DK256975A (da) Fremgangsmade til fremstilling af cephalosporiner og mellemliggende produkter
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
DK137539C (da) Fremgangsmaade til fremstilling af 11beta-fluor-4-androsten-3-oner